<?xml version="1.0" encoding="UTF-8"?>
<p id="p0150">
 <bold>Acute Ischemic stroke(AIS)</bold> has been reported in approximately 1-3% of patients with COVID-19 [
 <xref rid="bb0195" ref-type="bibr">39</xref>,
 <xref rid="bb0385" ref-type="bibr">77</xref>,
 <xref rid="bb0420" ref-type="bibr">84</xref>]; this is similar with other CoV infections (SARS-CoV-1 and MERS-CoV). During the current pandemic, 370 patients with SARS-CoV-2 infection out of 37 studies (
 <xref rid="t0015" ref-type="table">Table 3</xref>) were reported to suffer from AIS or transient ischemic attack (TIA). Most of these patients had several underlying co-morbidities which made them more susceptible to thromboembolic events. [
 <xref rid="bb0105" ref-type="bibr">21</xref>,
 <xref rid="bb0385" ref-type="bibr">77</xref>].
</p>
